A Subset of Toll-Like Receptor Ligands Induces Cross-presentation by Bone Marrow-Derived Dendritic Cells-Reference-Cited by-同舟云学术

A Subset of Toll-Like Receptor Ligands Induces Cross-presentation by Bone Marrow-Derived Dendritic Cells

Published:2003-04-15 Issue:8 Volume:170 Page:4102-4110
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Datta Sandip K.,Redecke Vanessa,Prilliman Kiley R.,Takabayashi Kenji,Corr Maripat,Tallant Thomas,DiDonato Joseph,Dziarski Roman,Akira Shizuo,Schoenberger Stephen P.,Raz Eyal

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

2. Mechanisms of Exogenous Antigen Presentation by MHC Class I Molecules in Vitro and in Vivo: Implications for Generating CD8+ T Cell Responses to Infectious Agents, Tumors, Transplants, and Vaccines

3. Cross-Presentation, Dendritic Cells, Tolerance and Immunity

4. Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens

5. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationship Studies in Benzothiadiazoles as Novel Vaccine Adjuvants;Journal of Medicinal Chemistry;2024-08-08

2. Controlled production of lipopolysaccharides increases immune activation in Salmonella treatments of cancer;Microbial Biotechnology;2024-05

3. Recognition of Mycobacterium tuberculosis by macrophage Toll-like receptor and its role in autophagy;Inflammation Research;2024-04-02

4. A comprehensive review on the dynamic role of toll-like receptors (TLRs) in frontier aquaculture research and as a promising avenue for fish disease management;International Journal of Biological Macromolecules;2023-12

5. Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy;Frontiers in Immunology;2023-10-23